Vitamin D receptor genotypes and response to zoledronic acid therapy in thalassemia-induced osteoporosis.
Otrock
Zaher K
ZK
Mahfouz
Rami A
RA
Charafeddine
Khalil M
KM
Rayes
Roni F
RF
Zahed
Laila F
LF
Taher
Ali T
AT
D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D015331:Cohort Studies; D004164:Diphosphonates / Q000627:therapeutic use*; D005838:Genotype; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D010024:Osteoporosis / Q000188:drug therapy* / Q000209:etiology; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D018167:Receptors, Calcitriol / Q000235:genetics*; D013789:Thalassemia / Q000150:complications; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D018167:Receptors, Calcitriol; D000077211:Zoledronic Acid